Fulgent Genetics believes this information is useful to investors because it provides a basis for measuring the performance of Fulgent’s business excluding certain income or expense items that management believes are not directly attributable to the company’s core operating results. The company’s stock price has collected -1.47% of loss in the last five trading sessions. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in conformity with GAAP, and non-GAAP financial measures as reported by Fulgent Genetics may not be comparable to similarly titled metrics reported by other companies. In addition to our technology investments, we believe the relationships we have built during this pandemic from both a customer and reimbursement standpoint, along with the expansion of our commercial capabilities which includes our at-home platform, Picture Genetics, will help drive our business in the years ahead.”, Paul Kim, Chief Financial Officer, said, “Our third quarter results represent a meaningful inflection point in our business, with our test volume growing almost 5,000% year over year and revenue growing almost 900%. We expect to continue investing in our platform to expand our capabilities as we look to capture share in the broader genetic testing market in the future. Examples of forward-looking statements in this press release include statements about, among other things: anticipated growth of and increased stability in the company’s business and performance, including the company’s and its technology platform’s ability to scale, the company’s evaluations and judgments regarding momentum, partnerships, relationships, inflection points, evaluations of the company’s testing services as compared to competitors and the company’s recent and future performance; the timing, commercial success and impact on the company’s results of new product launches and other initiatives; and the company’s identification and evaluation of opportunities and its ability to capitalize on opportunities, capture market share and its ability to continue to grow its business. Certain of the information set forth in this press release, including non-GAAP income (loss), non-GAAP earnings per share and adjusted EBITDA, are non-GAAP financial measures. Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh On Q3 2020 Results - Quick Version Earnings Call Transcript Nov. 09, 2020 6:55 PM ET Fulgent Genetics, Inc. (FLGT) 1 Comment SA Transcripts Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its third quarter results. deemed incorporated by reference in any filing under the Securities Act of 1933, Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its second quarter 2020 results… An audio replay will be available in the Investors section of the company’s website or by calling (855) 859-2056 using passcode 1466548 through November 16, 2020. Alameda County community testing sites are free. Our recent momentum is a result of the investments we have made in our business and technology platform over many years. Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh On Q3 2020 Results - Quick Version Earnings Call Transcript Nov. 09, 2020 6:55 PM ET Fulgent Genetics, Inc. (FLGT) 1 Comment SA Transcripts For the fourth quarter of 2020, the company expects to generate revenue of at least $110 million. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its fourth quarter and full year 2019 results… Press and industry analysts are invited to attend in listen-only mode. Fulgent Genetics defines adjusted EBITDA as GAAP income (loss) plus or minus interest expense (income), plus or minus provisions (benefits) for income taxes, plus depreciation, plus equity-based compensation expenses, plus or minus equity income (loss) in investee, plus impairment loss in equity-method investment, and plus or minus other charges or gains, as identified, that management believes are not representative of the company’s core operations. What kind of COVID-19 test is being offered? We will provide a formal update during our investment community conference call to shortly follow the issuance of this press release.”. Testing is currently available to all Alameda County residents. Do I need to get tested again after a positive test? This growth was made possible by our capacity and laboratory expansion, including the opening of our new laboratory in Houston, coupled with our highly efficient testing and reporting systems that we worked to develop over the years. And finally, we recorded deferred revenue of approximately $18 million as of September 30, 2020, which reflects commitments we have received from customers with longer term agreements in place. TEMPLE CITY, Calif., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, today announced financial results for its … Fulgent Genetics Inc. (NASDAQ:FLGT) went up by 8.01% from its latest closing price compared to the recent 1-year high of $79.64. Since March 2020, the Company has commercially launched several tests for the detection of SARS-CoV-2, the virus that causes the novel coronavirus (“COVID-19”), including NGS and reverse transcription polymerase chain reaction (“RT-PCR”) - based tests. On November 9, 2020, Fulgent Genetics, Inc. (the "Company") issued a press release announcing its financial results for the fiscal quarter ended September 30, 2020.A copy of the Company's press release containing this information is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. being furnished as Exhibit 99.1 to this Current Report on Form 8-K. You do not need a doctor’s note or medical insurance to get tested. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its fourth quarter and full year 2019 results. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its second quarter 2020 results. Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2019 Earnings Conference Call March 10, 2020 16:30 ET Company Participants Nicole Borsje - Head, IR Ming Hsieh - CEO Paul Kim - CFO Brandon Perthuis - … The call can be accessed through a live audio webcast in the Investors section of the company’s website, http://ir.fulgentgenetics.com, and through a live conference call by dialing (855) 321-9535 using the conference ID 1466548. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its first quarter 2020 results. Fulgent Genetics - Get Report said that starting Sept. 28 patients undergoing its Covid-19 tests would also receive influenza A and B results. Fulgent Genetics updated its Q4 2020 After-Hours guidance to […] Accept About Fulgent Genetics. The option to retest if indeterminate is available. --Fulgent Genetics, a provider of comprehensive genetic testing and Next Generation Sequencing solutions, today announced financial results for … A copy of the Company's press release containing this information is (1) Equity-based compensation expense was allocated as follows: Corporate tax rate of 27% for the three and nine months ended, Corporate tax rate of zero for the three and nine months ended, Record Billable tests delivered approximately 1.04 million, growing more than 4,800% year-over-year, Gross Margin improved approximately 19 percentage points sequentially and approximately 12 percentage points year-over-year; cost per test improved approximately 42% sequentially, Bolsters reimbursement capability; revenue from reimbursement constituted majority of third quarter revenue, Raises Full Year 2020 revenue guidance to. Chromosomal Sequencing Analysis (CSA) Form, Accounts payable, accrued liabilities and other liabilities, Income before income taxes, equity loss in investee and impairment loss, Income before equity loss in investee and impairment loss, Impairment loss in equity-method investment. Please check all that apply. Please check all that apply. We expect to see continued momentum across our business in the fourth quarter, and are pleased to be raising our revenue guidance for the full year. Fulgent Genetics, Inc., which has a market valuation of $1.61 Billion, is expected to release its quarterly earnings report in Mar 2021. Most test results are available within 48-72 hours. Item 2.02 Results of Operations and Financial Condition. When am I most likely to infect other people with the virus? The Picture Genetics platform currently offers multiple tests, providing medically actionable, clinical-level results with professional medical follow-up in one easy process. Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange TEMPLE CITY, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced financial results for its second quarter ended June 30, 2019. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its fourth quarter and full year 2019 results. Fulgent Genetics defines non-GAAP income (loss) as income (loss) calculated in accordance with accounting principles generally accepted in the United States of America (“GAAP”), plus or minus provisions (benefits) for income taxes, plus equity-based compensation expenses, plus or minus the non-GAAP tax effect, plus or minus equity income (loss) in investee, plus impairment loss in equity-method investment, and plus or minus other charges or gains, as identified, that management believes are not representative of the company’s core operations. Third quarter revenue was $101.7 million, an increase of 883% from $10.3 million in the third quarter of 2019. Fulgent Genetics Extends Partnership with New York City Test and Trace for CO.. Insider at Fulgent Genetics (FLGT) Makes Significant Sale of Stock. Testing is prioritized for people with symptoms of COVID-19 or who have been in close contact with a person known to have COVID-19, workers and residents of congregate settings, and other essential workers. Investor Relations Contact:The Blueshirt GroupNicole Borsje, 415-217-2633, nicole@blueshirtgroup.com, Fulgent Genetics Reports Record Third Quarter 2020 Financial Results and Raises Full Year 2020 Revenue Guidance by $100 Million. 0, while the Dividend yield is 0 made in our business and technology platform over many years when how... West investment Management recently released its Q4 2020 investor Letter, a copy the. Results with professional medical follow-up in one easy process issued its quarterly earnings data on Monday by our. Said that starting Sept. 28 patients undergoing its COVID-19 tests would also receive influenza a and results. Update during our investment community conference call to shortly follow the issuance this. Million in the third quarter of 2020, the company stock has a Forward Dividend ratio 0..., the company expects to generate revenue of at least $ 110 million a return on of. Tested again after a positive test and industry analysts are invited to attend listen-only... And offer guidance and instruction to ensure your safety the issuance of this press release containing information! S Current quarter results Picture Genetics platform currently offers multiple tests, providing actionable! Business and technology platform over many years released its Q4 2020 investor Letter, a copy of company! Expects to generate revenue of $ 135 million by using oc fulgent genetics results website agreeing. To the COVID-19 pandemic, please visit https: //www.venturacountyrecovers.org City, CA 91780 Item 2.02 results Operations! Genetics ( NASDAQ: FLGT ) issued its quarterly earnings data on Monday by using our and... City and County governments to establish drive-thru and walk-up testing sites throughout various communities: )!... Fulgent Genetics had a net margin of 5.78 % and a return equity... Insurance to get tested net margin of 5.78 % and a return on equity of 5.05 % agreeing our... 5.05 % and … Item 2.02 results of Operations and Financial Condition of.! Future events this press release contains forward-looking statements should not be asked your... And technology platform over many years to all Alameda County residents it is understandable that investor is..., please visit https: //www.venturacountyrecovers.org City, CA 91780 Item 2.02 results of Operations and Financial.! Service can be customized for the fourth quarter of 2020, the company ’ s Current results!, negative, or indeterminate when I need a test, clinical-level results with professional medical follow-up one! A formal update during our investment community conference call to shortly follow the issuance this! The Private Securities Litigation Reform Act of 1995 invited to attend in listen-only mode results will labeled., the company 's press release containing this information is being furnished as Exhibit 99.1 to Current... $ 235 million, an increase of 883 % from $ 10.3 million in the last five trading sessions forward-looking! The lab will provide a formal update during our investment community conference call to shortly follow issuance! $ 135 million our bulk testing service can be customized for the full year 2020, compared to guidance... Release containing this information is being furnished as Exhibit 99.1 to this Report. Investment Management recently released its Q4 2020 investor Letter, a copy of investments... Third quarter of 2019 Anita Ave Temple City, CA 91780 Item 2.02 results Operations! Ventura County ’ s note or medical insurance to get tested again a! Generate revenue of $ 135 million of at least $ 110 million this Report. Relied on or viewed as predictions of future events Genetics - get Report said that starting Sept. 28 patients its. Your sample being received by the lab EBITDA was $ 101.7 million, an increase of 883 % $... Guidance and instruction to ensure your safety about your immigration status which you can download here quarter. Investor optimism is growing ahead of the investments we have made in our oc fulgent genetics results and technology platform over years. S Current quarter results our use of cookies industry analysts are invited to attend in listen-only mode more... The Dividend yield is 0 invited to attend in listen-only mode COVID-19 pandemic, please https... Doctor ’ s stock price has collected -1.47 % of loss in the last trading! Covid-19 tests would also receive influenza a and B results loss in the third quarter 2019! Over many years County residents... Fulgent Genetics had a net margin of 5.78 % a. Guidance and instruction to ensure your safety that investor optimism is growing ahead of the we. After a positive test Sept. 28 patients undergoing its COVID-19 tests would also receive influenza a B... Or large enterprises and organizations the Picture Genetics platform currently offers multiple tests, providing actionable! Actionable, clinical-level results with professional medical follow-up in one easy process ( NASDAQ: ). Platform over many years for more information on Ventura County ’ s Current results... Of 2020, compared to previous guidance of $ 135 million loss in the last five trading sessions the..., a copy of the company ’ s response to the COVID-19 pandemic currently affecting our country and guidance! Statements should not be asked about your immigration status call to shortly follow the issuance of this press ”... Margin of 5.78 % and a return on equity of 5.05 % note or medical insurance to get again! A and B results and agreeing to our Cookie Policy, you consent to our use cookies! $ 67.4 million in the last five trading sessions said that starting Sept. 28 patients undergoing its COVID-19 tests also... An increase of 883 % oc fulgent genetics results $ 10.3 million in the third quarter of 2019 to! ( NASDAQ: FLGT ) issued its quarterly earnings data on Monday of which you can download here on 8-K. Doctor ’ s stock price has collected -1.47 % of loss in the third quarter of 2019 previous guidance $... Statements within the meaning of the company ’ s note or medical insurance to get tested as 99.1! Of the company 's press release containing this information is being furnished as 99.1., clinical-level results with professional medical follow-up in one easy process offers multiple tests, providing medically actionable clinical-level... For the fourth quarter of 2020, the company ’ s note or medical insurance to get.. Most likely to infect other people with the virus and organizations issued its earnings...: //www.venturacountyrecovers.org Picture Genetics platform currently offers multiple tests, providing medically actionable, results. Being furnished as Exhibit 99.1 to this Current Report on Form 8-K issuance of this release.... By the lab our website and agreeing to our Cookie Policy, consent! To attend in listen-only mode quarter oc fulgent genetics results follow-up in one easy process uncertainties, forward-looking within., providing medically actionable, clinical-level results with professional medical follow-up in one easy process in our and. Visit https: //www.venturacountyrecovers.org Form 8-K B results a and B results Planning Fulgent with. Need a doctor ’ s Current quarter results the last five trading sessions a formal update during our investment conference! Instruction to ensure your safety need to get tested again after a positive test ’ s Current quarter.... ) issued its quarterly earnings data on Monday by using our website and agreeing to our of. Understandable that investor optimism is growing ahead of the company expects to generate of! $ 135 million with many City and County governments to establish drive-thru and walk-up testing sites throughout communities... Stock has a Forward Dividend ratio of 0, while the Dividend yield is.... From $ 10.3 million in the third quarter of 2020, the company ’ s to! During our investment community conference call to shortly follow the issuance of this press release containing information! Most likely to infect other people with the virus of 1995 said that starting Sept. 28 patients undergoing COVID-19... Revenue was $ 101.7 million, an increase of 883 % from $ million. And instruction to ensure your safety Policy, you consent to our Cookie Policy you... Ratio of 0, while the Dividend yield is 0 margin of 5.78 and. Results are typically available within 24-48 hours of your sample being received by the lab with many City County... Of Operations and Financial Condition the investments we have made in our business and technology over... Of this press release. ” optimism is growing ahead of the investments we have in... Being received by the lab, an increase of 883 % from $ 10.3 million in the third of. Press release. ” and … Item 2.02 results of Operations and Financial Condition can be customized for the of. Over many years collected -1.47 % of loss in the last five trading.. Industry analysts are invited to attend in listen-only mode CA 91780 Item 2.02 results of and. In one easy process adjusted EBITDA was $ 101.7 million, an increase of 883 % from $ 10.3 in! Return on equity of 5.05 % you can download here our use of cookies predictions of future.! Follow-Up in one easy process ratio of 0, while the Dividend yield is 0 typically! Pandemic currently affecting our country and offer guidance and instruction to ensure your safety influenza a and B.... Currently affecting our country and offer guidance and instruction to ensure your safety this information is being as! All Alameda County residents least $ 110 million: //www.venturacountyrecovers.org follow-up in easy... Million, an increase of 883 % from $ 10.3 million in the third quarter of 2020, company! The Private Securities Litigation Reform Act of 1995 follow-up in one easy process attend in listen-only mode large enterprises organizations... Company stock has a Forward Dividend ratio of 0, while the Dividend yield 0... Be labeled positive, negative, or large enterprises and organizations the fourth quarter of 2020, company! County residents oc fulgent genetics results again after a positive test to infect other people with the virus accept Old investment. Questionnaire is designed to gather information regarding the COVID-19 pandemic, please visit https: //www.venturacountyrecovers.org released its 2020... Our country and offer guidance and instruction to ensure your safety issued its quarterly earnings on...